Singapore’s banks reported mixed quarterly results and the NASDAQ slid into a correction, while Grab raised its full-year outlook and SGX RegCo will take on prospectus reviews.
Browsing: Blue Chips
The STI ETF fell 5.5% in October, but four blue-chip S-REITs stayed in the green. FCT, CICT, FLCT and MLT also outperformed the broader S-REIT index.
OCBC delivered record profit in 1H2026, but fees, trading and insurance drove much of the growth. Here are three key metrics to watch ahead of its 3Q update.
The STI fell 5.5% in October, but four SGX blue chips stayed in the green. DFI Retail, Jardine Matheson, Hongkong Land and Sembcorp Industries delivered positive total returns despite the market downturn.
DBS reports on 5 November, giving investors a fresh look at margins, fee income and earnings as lower interest rates put pressure on its lending business.
With stock markets experiencing uncertainty, investors face a familiar dilemma: should you buy stocks now or wait for prices to fall further?
DBS, Singtel and Microsoft offer three very different ways to build a long-term portfolio, combining dividend income, defensive cash flow and global growth potential.
Here’s the key metrics to watch when UOB steps up to deliver its latest quarter’s earnings — the first among the big three banks to do so.
Three STI blue chips pay dividends in November 2026, but investors should look beyond payment dates to assess the sustainability of future payouts.
Three SGX blue chips offer dividend yields above 6.5%, but investors should look beyond the headline yield to understand what is funding each payout.
Three Temasek-linked blue chips report results in early November as Middle East tensions create different challenges for each company. Here’s what investors should watch.
Singapore Exchange shares have delivered impressive returns, supported by stronger trading activity and growing investor interest in Singapore stocks. But after their rally, is SGX still attractively valued?
Three Temasek-linked blue-chip S-REITs report this week, with CICT, CLAR and MPACT in focus as investors assess DPU growth and distribution sustainability.
Venture Corporation’s cash-rich balance sheet has supported decades of dividends, but investors should ask whether its earnings and free cash flow can sustain the payout.
Opportunity cost looks like discipline. But more often than not, it’s the pain of loss looking for an exit.
Three Temasek-backed S-REITs yield more than 6.5%, but the highest yield does not necessarily mean the best investment. Here’s how their DPU growth compares.
DBS, OCBC and UOB are among Singapore’s most popular dividend stocks, but which offers the best investment opportunity today?
MIT, MLT and Keppel are in focus this week after a series of asset sales. Here’s what income investors should watch for in their latest results.
The STI has pulled back from its 52-week high, but DBS, ST Engineering and SGX continue to outperform, driven by strong underlying businesses.
The STI is 7% below its 52-week high, putting three Temasek-linked S-REITs in focus as investors assess whether their underlying distributions remain resilient.